This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01494/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB01494/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01494/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB01494/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01494
rdf:type
n3:Drug
n3:group
illicit withdrawn
owl:sameAs
n6:DB01494 n13:DB01494
dcterms:title
Chloral betaine
adms:identifier
n8:16676 n9:46508513 n11:15813 n12:DB01494
n3:synthesisReference
Petrow, V., Thomas, A.J. and Stephenson, O.; U.S. Patent 3,028,420; April 3,1962; assigned to The British Drug Houses Limited, England.
n3:IUPAC-Name
n4:271B4FC3-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4FC9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4FC8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4FC5-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4FC6-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4FC7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4FC2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4FCF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4FD0-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4FCA-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4FCB-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4FCD-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4FCC-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4FCE-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
2218-68-0
n3:Bioavailability
n4:271B4FD4-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4FD6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4FD7-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4FD8-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4FD3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4FD2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4FD5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4FC4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4FD1-363D-11E5-9242-09173F13E4C5